Literature DB >> 1977308

Genetics and biology of human ovarian teratomas. II. Molecular analysis of origin of nondisjunction and gene-centromere mapping of chromosome I markers.

R Deka1, A Chakravarti, U Surti, E Hauselman, J Reefer, P P Majumder, R E Ferrell.   

Abstract

Chromosomal heteromorphisms and DNA polymorphisms have been utilized to identify the mechanisms that lead to formation of human ovarian teratomas and to construct a gene-centromere map of chromosome 1 by using those teratomas that arise by meiotic nondisjunction. Of 61 genetically informative ovarian teratomas, 21.3% arose by nondisjunction at meiosis I, and 39.3% arose by meiosis II nondisjunction. Eight polymorphic marker loci on chromosome 1p and one marker on 1q were used to estimate a gene-centromere map. The results show clear linkage of the most proximal 1p marker (NRAS) and the most proximal 1q marker (D1S61) to the centromere at a distance of 14 cM and 20 cM, respectively. Estimated gene-centromere distances suggest that, while recombination occurs normally in ovarian teratomas arising by meiosis II errors, ovarian teratomas arising by meiosis I nondisjunction have altered patterns of recombination. Furthermore, the estimated map demonstrates clear evidence of chiasma interference. Our results suggest that ovarian teratomas can provide a rapid method for mapping genes relative to the centromere.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977308      PMCID: PMC1683806     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Crossing-over and interference in a multiply marked chromosome arm of Neurospora.

Authors:  D D PERKINS
Journal:  Genetics       Date:  1962-09       Impact factor: 4.562

2.  Benign cystic teratomas of the ovary; a clinico-statistical study of 1,007 cases with a review of the literature.

Authors:  W F PETERSON; E C PREVOST; F T EDMUNDS; J M HUNDLEY; F K MORRIS
Journal:  Am J Obstet Gynecol       Date:  1955-08       Impact factor: 8.661

3.  Parthenogenic origin of benign ovarian teratomas.

Authors:  D Linder; B K McCaw; F Hecht
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

4.  Ovarian teratomas: cytologic data.

Authors:  B K McCaw; F Hecht; D Linder; E W Lovrien; H Wyandt; D Bacon; B Clark; N Lea
Journal:  Cytogenet Cell Genet       Date:  1976

5.  Origin of teratomas and twins.

Authors:  S Shahar; N E Morton
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

6.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

7.  Estimating distances from the centromere by means of benign ovarian teratomas in man.

Authors:  J Ott; D Linder; B K McCaw; E W Lovrien; F Hecht
Journal:  Ann Hum Genet       Date:  1976-11       Impact factor: 1.670

8.  Application of the ovarian teratoma mapping method in the mouse.

Authors:  J T Eppig; E M Eicher
Journal:  Genetics       Date:  1983-04       Impact factor: 4.562

9.  The origin of ovarian teratomas.

Authors:  J M Parrington; L F West; S Povey
Journal:  J Med Genet       Date:  1984-02       Impact factor: 6.318

10.  The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors.

Authors:  P Krieg; E Amtmann; G Sauer
Journal:  Anal Biochem       Date:  1983-10-15       Impact factor: 3.365

View more
  21 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  Statistical analysis of ordered tetrads.

Authors:  H Zhao; T P Speed
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

4.  Statistical analysis of half-tetrads.

Authors:  H Zhao; T P Speed
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

5.  Fetiform teratoma was a parthenogenetic tumor arising from a mature ovum.

Authors:  Kiyonori Miura; Takumi Kurabayashi; Chisei Satoh; Kensaku Sasaki; Tatsuya Ishiguro; Koh-Ichiro Yoshiura; Hideaki Masuzaki
Journal:  J Hum Genet       Date:  2017-04-27       Impact factor: 3.172

6.  Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis.

Authors:  Olivia L Snir; Maura DeJoseph; Serena Wong; Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

7.  Two types of primary mucinous ovarian tumors can be distinguished based on their origin.

Authors:  Michiel Simons; Femke Simmer; Johan Bulten; Marjolijn J Ligtenberg; Harry Hollema; Shannon van Vliet; Richarda M de Voer; Eveline J Kamping; Dirk F van Essen; Bauke Ylstra; Lauren E Schwartz; Yihong Wang; Leon F Massuger; Iris D Nagtegaal; Robert J Kurman
Journal:  Mod Pathol       Date:  2019-11-06       Impact factor: 7.842

8.  Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy.

Authors:  A Mutirangura; F Greenberg; M G Butler; S Malcolm; R D Nicholls; A Chakravarti; D H Ledbetter
Journal:  Hum Mol Genet       Date:  1993-02       Impact factor: 6.150

9.  Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients.

Authors:  S L Christian; W P Robinson; B Huang; A Mutirangura; M R Line; M Nakao; U Surti; A Chakravarti; D H Ledbetter
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

10.  Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas.

Authors:  Ashwini Balakrishnan; J Richard Chaillet
Journal:  Dev Biol       Date:  2012-10-16       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.